DAWN
$21.29
Day One Biopharmaceuticals, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for childhood and adult diseases with equal intensity in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Day One Biopharmaceuticals, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for childhood and adult diseases with equal intensity in the United States. The company's l...
Recent News
A Look At Day One Biopharmaceuticals (DAWN) Valuation After Recent Share Price Momentum
Day One Biopharmaceuticals (DAWN) has drawn investor attention after strong recent share performance, with returns of 65% over the past week and 81% over the past month, prompting closer review of its fundamentals. See our latest analysis for Day One Biopharmaceuticals. With the share price now at $21.25, Day One Biopharmaceuticals has seen strong momentum recently, including a 90 day share price return of 152.38% and a 1 year total shareholder return of 141.75%. This suggests investors are...
Oracle, Nike upgraded: Wall Street's top analyst calls
Oracle, Nike upgraded: Wall Street's top analyst calls
Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More
Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn’t see the snapback rally that was the star of the show Monday, at least all four major indices held their own as the conflict in Iran grinds on. The Nasdaq was able to eke out ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More
Qualcomm downgraded, Rivian upgraded: Wall Street's top analyst calls
Qualcomm downgraded, Rivian upgraded: Wall Street's top analyst calls
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More
Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil futures, which shot up to $120 overnight, retreated below $100 on Monday. That was the biggest spike in oil pricing since 2020. With the retreat in the black gold, the major indices did a massive ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More